These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17893231)

  • 1. Phosphoinositol phosphatase SHIP2 promotes cancer development and metastasis coupled with alterations in EGF receptor turnover.
    Prasad NK; Tandon M; Badve S; Snyder PW; Nakshatri H
    Carcinogenesis; 2008 Jan; 29(1):25-34. PubMed ID: 17893231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHIP2 phosphoinositol phosphatase positively regulates EGFR-Akt pathway, CXCR4 expression, and cell migration in MDA-MB-231 breast cancer cells.
    Prasad NK
    Int J Oncol; 2009 Jan; 34(1):97-105. PubMed ID: 19082482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein phosphatase 2A PR130/B''alpha1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling.
    Zwaenepoel K; Goris J; Erneux C; Parker PJ; Janssens V
    FASEB J; 2010 Feb; 24(2):538-47. PubMed ID: 19825976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of obesity-linked phosphatase SHIP2 in invasive breast cancer correlates with reduced disease-free survival.
    Prasad NK; Tandon M; Handa A; Moore GE; Babbs CF; Snyder PW; Bose S
    Tumour Biol; 2008; 29(5):330-41. PubMed ID: 19065064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SH2-containing 5'-inositol phosphatase, SHIP2, regulates cytoskeleton organization and ligand-dependent down-regulation of the epidermal growth factor receptor.
    Prasad NK; Decker SJ
    J Biol Chem; 2005 Apr; 280(13):13129-36. PubMed ID: 15668240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity.
    Sasaoka T; Wada T; Tsuneki H
    Pharmacol Ther; 2006 Dec; 112(3):799-809. PubMed ID: 16842857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners.
    Onnockx S; De Schutter J; Blockmans M; Xie J; Jacobs C; Vanderwinden JM; Erneux C; Pirson I
    J Cell Physiol; 2008 Jan; 214(1):260-72. PubMed ID: 17620296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel oncogenic role of inositol phosphatase SHIP2 in ER-negative breast cancer stem cells: involvement of JNK/vimentin activation.
    Fu CH; Lin RJ; Yu J; Chang WW; Liao GS; Chang WY; Tseng LM; Tsai YF; Yu JC; Yu AL
    Stem Cells; 2014 Aug; 32(8):2048-60. PubMed ID: 24802135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
    Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
    Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via phosphatidylinositol 3-Kinase-dependent Rac1 activation.
    Zhuang G; Hunter S; Hwang Y; Chen J
    J Biol Chem; 2007 Jan; 282(4):2683-94. PubMed ID: 17135240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
    Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
    Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SHIP2 multiple functions: a balance between a negative control of PtdIns(3,4,5)P₃ level, a positive control of PtdIns(3,4)P₂ production, and intrinsic docking properties.
    Erneux C; Edimo WE; Deneubourg L; Pirson I
    J Cell Biochem; 2011 Sep; 112(9):2203-9. PubMed ID: 21503961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High SHIP2 expression indicates poor survival in colorectal cancer.
    Yang J; Fu M; Ding Y; Weng Y; Fan W; Pu X; Ge Z; Zhan F; Ni H; Zhang W; Jin F; Xu N; Li J; Qiu L; Wang J; Gu X
    Dis Markers; 2014; 2014():218968. PubMed ID: 25525286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylinositol 3,4,5-trisphosphate modulation in SHIP2-deficient mouse embryonic fibroblasts.
    Blero D; Zhang J; Pesesse X; Payrastre B; Dumont JE; Schurmans S; Erneux C
    FEBS J; 2005 May; 272(10):2512-22. PubMed ID: 15885100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2.
    Dyson JM; Kong AM; Wiradjaja F; Astle MV; Gurung R; Mitchell CA
    Int J Biochem Cell Biol; 2005 Nov; 37(11):2260-5. PubMed ID: 15964236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional profiling of C2C12 myotubes in response to SHIP2 depletion and insulin stimulation.
    Huard C; Martinez RV; Ross C; Johnson JW; Zhong W; Hill AA; Kim R; Paulsen JE; Shih HH
    Genomics; 2007 Feb; 89(2):270-9. PubMed ID: 17123777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors.
    Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M
    Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of anionic lipids on SHIP2 phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase activity.
    Vandeput F; Backers K; Villeret V; Pesesse X; Erneux C
    Cell Signal; 2006 Dec; 18(12):2193-9. PubMed ID: 16824732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the liver-specific expression of SHIP2 (SH2-containing inositol 5'-phosphatase 2) on insulin signaling and glucose metabolism in mice.
    Fukui K; Wada T; Kagawa S; Nagira K; Ikubo M; Ishihara H; Kobayashi M; Sasaoka T
    Diabetes; 2005 Jul; 54(7):1958-67. PubMed ID: 15983195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalization of prandial blood glucose and improvement of glucose tolerance by liver-specific inhibition of SH2 domain containing inositol phosphatase 2 (SHIP2) in diabetic KKAy mice: SHIP2 inhibition causes insulin-mimetic effects on glycogen metabolism, gluconeogenesis, and glycolysis.
    Grempler R; Zibrova D; Schoelch C; van Marle A; Rippmann JF; Redemann N
    Diabetes; 2007 Sep; 56(9):2235-41. PubMed ID: 17596404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.